BIO Advanced Business Development Course 2013
November 1–3, 2013
Hilton Vienna Danube
Attendance is limited to 75 participants to ensure the optimal instructor/student ratio and quality interaction.
Take your skills to the next level by working
directly with colleagues in a hands-on, practical course
that uses a realistic business case!
The Advanced Business Development Course is designed
for business development professionals interested in bringing
their skills in valuation, due diligence, negotiation
and contracts to the next level. During this intensive,
three-day session attendees will receive advanced hands-on
training from veteran business development professionals
and legal advisers using real-world case studies. Delegates will work in teams to successfully negotiate a term sheet for a clinical stage compound.
This course has been organized for life science business development professionals by the Biotechnology Industry Organization in collaboration with EBD Group. The faculty is drawn from among the most experienced business development professionals in the biotech drug development industry as well as big pharma, many of whom have been instructors in other programs, and all of whom have extensive experience in the biotech industry.
The course will cover basic topics and skills crucial
to every business development professional in the industry,
- Valuation skills
- Intellectual property
- Due diligence
- Negotiation and influence strategies
- Contracts in depth
Who should attend?
Although this course is recommended for business development
professionals with approximately 3–5 years experience,
it is highly recommended to ambitious individuals with demanding
business development and senior management goals. It is designed for business development
professionals who have most likely served as part of a
business development or licensing team, but are now preparing
to move to a senior manager role within their organization.
- Business development and licensing professionals
- Alliance management professionals
- R&D personnel who have significant interaction
with business development
- Intellectual property personnel involved in the licensing
- Biotech company CEOs
Attendance is limited to 75 participants to ensure
the optimal instructor/student ratio and quality interaction.
And stay for the BIO-Europe®
international partnering conference,
which starts immediately after this course finishes.